每周特立帕肽给药与融合节段邻近头侧椎体术前前滑移小于2毫米促进后路腰椎椎间融合术后骨性融合
这项多中心病例对照研究分析了66例接受后路腰椎椎间融合术的骨质疏松老年女性,发现每周特立帕肽给药和融合节段邻近头侧椎体术前前滑移小于2毫米是术后6个月内骨性融合的独立预测因素,融合组股骨颈骨密度平均增加1.1%而非融合组下降1.3%。
要点
- 每周特立帕肽给药与PLIF术后6个月内骨性融合独立相关(OR 4.75)。
- 融合节段邻近头侧椎体术前前滑移小于2毫米与骨性融合独立相关(OR 5.90)。
- 融合组股骨颈骨密度平均增加1.1%,非融合组平均下降1.3%(P<0.05)。
核心结论
- 每周特立帕肽给药和融合节段邻近头侧椎体术前前滑移小于2毫米是PLIF术后6个月内骨性融合的独立预测因素。
- 作者认为生物学和力学因素可能影响脊柱融合的改善。
研究设计与样本
- 多中心病例对照研究,纳入2011年至2014年接受PLIF的66例骨质疏松老年患者(全部为女性,平均年龄71岁,随访期至少6个月)。
- 患者被随机分配为术后1周开始每周特立帕肽治疗组或不接受特立帕肽组。
- 术前获取腰椎X线片并测量前滑移量,术后6个月通过计算机断层扫描评估骨性融合。
主要发现
- 33例患者(50%)显示完全骨性融合,33例未融合。
- 融合组20例(61%)接受特立帕肽治疗,非融合组9例(27%)接受特立帕肽治疗(P<0.01)。
- 融合组16例(49%)和非融合组4例(12%)存在融合节段邻近头侧椎体术前前滑移小于2毫米(P<0.01)。
- 多因素回归分析显示特立帕肽给药(比值比4.75;95%置信区间:1.51-14.90;P<0.01)和融合节段邻近头侧椎体术前前滑移小于2毫米(比值比5.90;95%置信区间:1.53-22.70;P<0.01)与PLIF术后6个月内骨性融合独立相关。
- 术后6个月,融合组平均股骨颈骨密度显著增加1.1%,非融合组平均下降1.3%(P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A multicenter case-control study. OBJECTIVE: The aim of this study was to investigate the independent predictors of osseous union after posterior lumbar interbody fusion (PLIF). SUMMARY OF BACKGROUND DATA: PLIF is usually performed to treat lumbar degenerative diseases in elderly patients. Some patients exhibit intervertebral pseudoarthrosis. METHODS: We analyzed 66 elderly patients with osteoporosis who underwent PLIF from 2011 to 2014 (all women, mean age 71 years, follow-up period ≥6 months). Patients were randomly allocated to receive either treatment with weekly teriparatide, starting at 1 week postoperatively, or no teriparatide. Preoperative lumbar spine radiographs were obtained, and the amount of anterior slippage was measured. Osseous union was assessed by computed tomography at 6 months postoperatively. RESULTS: Thirty-three patients (50%) showed complete osseous union, while 33 did not. Teriparatide was administered in 20 (61%) patients of the union group and in 9 (27%) patients of the nonunion group (P < 0.01). The preoperative anterior slippage of the cranial vertebra next to fusion segment < 2 mm was observed in 16 (49%) and 4 (12%) patients in the union and nonunion groups, respectively (P < 0.01). Multivariate regression analysis showed that teriparatide administration (odds ratio, 4.75; 95% confidence interval: 1.51-14.90; P < 0.01) and preoperative anterior slippage of the cranial vertebra next to fusion segment < 2 mm (odds ratio, 5.90; 95% confidence interval: 1.53-22.70; P < 0.01) were independently associated with osseous union within 6 months after PLIF. At 6 months postoperatively, the mean femoral neck bone mineral density significantly increased by 1.1% in the union group and decreased by 1.3% in the nonunion group (P < 0.05). CONCLUSION: Weekly teriparatide administration and preoperative anterior slippage of the cranial vertebra next to fusion segment < 2 mm were independent predictors of osseous union within 6 months after PLIF. Our findings suggest that biological and mechanical factors may influence the improvement of spinal fusion. LEVEL OF EVIDENCE: 4.
引用
- Ushirozako H, Hasegawa T, Ebata S, et al. Weekly Teriparatide Administration and Preoperative Anterior Slippage of the Cranial Vertebra Next to Fusion Segment < 2 mm Promote Osseous Union After Posterior Lumbar Interbody Fusion. Spine (Phila Pa 1976). 2019. PMID: 30095791. doi:10.1097/BRS.0000000000002833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。